{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-024807","form_type":"8-K","ticker":"TECH","cik":"0000842023","company_name":"BIO-TECHNE Corp","filed_at":"2021-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.816252+00:00","generated_at":"2026-06-28T15:27:16.956396+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bio-Techne Q1 FY2022 revenue $257.7M, organic growth 21%; adjusted EPS $1.83 vs $1.43","bullets":["Q1 FY2022 revenue $257.7M, organic growth 21% (reported 26%).","GAAP EPS $1.69, adjusted EPS $1.83 vs $1.43 prior year.","Protein Sciences organic growth 26% (third consecutive quarter >20%).","China revenue grew over 50% organic; North America and Europe at least 20%.","Board declared $0.32 per share dividend payable Nov 26, 2021 to holders of record Nov 12."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-024807","json":"https://secwatch.observer/filing/0001437749-21-024807.json","markdown":"https://secwatch.observer/filing/0001437749-21-024807.md","text":"https://secwatch.observer/filing/0001437749-21-024807.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/842023/000143774921024807/0001437749-21-024807-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/842023/000143774921024807/tech20211101_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T15:27:16.956396+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}